Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Parkinson's drugs come under scrutiny

MagazineMay 2005 (Vol. 16 Issue 2)Parkinson's drugs come under scrutiny

Levodopa's ability to reduce the distressing symptoms of early-stage Parkinson's disease has earned itself enough street cred to become the first-line treatment for the condition

Levodopa's ability to reduce the distressing symptoms of early-stage Parkinson's disease has earned itself enough street cred to become the first-line treatment for the condition. However, there's a flip-side to every coin, and this drug is no exception.

Researchers at Columbia University in New York tested the drug on 361 patients with early Parkinson's and, as expected, found that levodopa helped to alleviate the stiffness, tremors, spasms and poor muscle control associated with the neurodegenerative disorder.

However, on scanning the patients' brains, they discovered that the drug was actually causing damage to nerve endings - in particular, to the dopamine receptors that play an important role in controlling symptoms.

In other words, while patients need the drug to ease symptoms, they are also accelerating the progress of the disease. So far, this paradox has left scientists stumped, with a big question mark hanging over how the long-term use of levodopa will affect patients with Parkinson's (N Engl J Med, 2004; 351: 2547-9).

Another drug under the microscope is rivastigmine, usually prescribed for people with Alzheimer's. A research team in Istanbul decided to try it for mild-to-moderate dementia related to advanced Parkinson's. While 19.8 per cent of patients improved in symptoms, 13 per cent got worse. To top it off, 29 per cent reported nausea, 17 per cent suffered vomiting and 10 per cent had tremors (N Engl J Med, 2004; 351: 2509-18).


The best alternative treatment for . . . raynaud's syndrome

So you think you need . . . a vasectomy

You may also be interested in...

Sign up for free today

Sign up now to get your FREE 17-point Plan to Great Health

Free membership gives you access to our latest news reports, use of our community area, forums, blogs, readers' health tips and our twice-weekly
e-news letter.

WDDTY Recommends

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, cancer, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2016 WDDTY Publishing Ltd.
All Rights Reserved